What's Driving the Weight Loss and Obesity Management Market Growth? Novo Nordisk A/S, GlaxoSmithKline plc., F. Hoffmann-La Roche AG, Allergan Plc, Johnson & Johnson Services

The growth of weight loss and obesity management market is attributed to the rising epidemic of obesity across the globe. According to the latest research by Future Market Insights (FMI), the global weight loss and obesity management market is anticipated to reach a valuation of over US$ 4.9 Bn, by the end of 2028. The weight loss and obesity management market is expected to expand at a steady CAGR of 5.2%, over the forecast period of 2018-2028.

A few key players featured in the weight loss and obesity management market report include Novo Nordisk A/S, GlaxoSmithKline plc., F. Hoffmann-La Roche AG, Allergan Plc, Johnson & Johnson Services, Inc, Medtronic plc., Vivus Inc., Eisai Co., Ltd., ReShape Lifesciences, Inc, Obalon Therapeutics, Aspire Bariatrics, Allurion Technologies Inc., Nalpropion Pharmaceuticals, Inc., and Beijing Noble Laser Technology Co., Ltd.

Developing Regions More Prone to Obesity & Other Comorbidities

Increasing number of cases of obesity and related comorbidities will lead to the growing adoption of drugs and devices for weight loss and obesity management, which will further fuel the growth of the global weight loss and obesity management market during the forecast period.

Request to Download a Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-411

The weight loss and obesity management market is majorly driven by the rising prevalence of obesity. The rising epidemic of obesity presents a major challenge to disease prevention across the globe. It is estimated that by 2030, 38% of the world’s adult population will be overweight and around 20% will be obese. This obesity epidemic is more prevalent in the Middle East and the Asia Pacific regions where food import is quite high. Weight loss and obesity management are helpful in the treatment of highly critical obesity and comorbidities associated with it, such as diabetes, asthma, sleep apnea, and hypertension, etc.

Increasing health consciousness is also cited as an important factor boosting the revenue growth of the global weight loss and obesity management market. Sizeable consumer population in developed regional markets will particularly continue to generate high demand for weight loss and obesity management practices, according to the report. Millennial and Generation-X consumers are gradually adopting advanced aesthetic services, including weight loss and obesity management, thereby creating adequate opportunities for manufacturers of weight loss and obesity management drugs and devices.

Key Vendors Targeting Extension of Product Portfolio

Leading companies operating in weight loss and obesity management market are majorly focusing on strengthening their product portfolio. Product line extensions help companies to launch newer products with unique features for specific indications. This results in an increased market share of companies in the highly competitive weight loss and obesity management market. In response to increasing demand from various healthcare professionals to effectively treat obesity with minimum long-term side effects, manufacturers are focusing on developing innovative and specific products.

Product innovation is expected to boost revenue and volume growth of the weight loss and obesity management market during the forecast period. For instance, an additional FDA patents approval for VIVUS, Inc.’s Qsymia, for the covering compositions of Qsymia and covering methods for effecting weight loss using Qsymia (phentermine and topiramate).

However, the high cost involved in research and development of obesity drugs is a great challenge for the growth of the weight loss and obesity management market. Additionally, long gestation time required for research and developmental activities as well as the need for a number of essential clinical trials to test drugs adds up to significant expenditure. The limitations posed by high development cost of anti-obesity drugs might hinder the growth of the global weight loss and obesity management market. Moreover, the high cost of surgical procedures, such as gastric bypass surgery, adjustable gastric banding, gastric sleeve surgery and gastric balloon treatment, may also affect the growth of the global weight loss and obesity management market adversely.

Needs More Detailed Information about Methodology @ https://www.futuremarketinsights.com/askus/rep-gb-411

The global weight loss and obesity management market is estimated based on product type, and distribution sales. Based on product type, the weight loss and obesity management market has been segmented into drugs and devices.

Drugs product type segment is further segmented into GLP-1 receptor agonists, lipase inhibitors, serotonin receptor agonist, a combination drug, and others. Devices product type segment is further segmented into liposuction devices, bariatric stapling devices, gastric band, gastric balloon systems, gastric emptying systems, and gastric electrical stimulation systems.

Devices segment is expected to hold maximum market share in the global weight loss and obesity management market. Based on distribution sales, the weight loss and obesity management market has been segmented into institutional sales and retail sales. In terms of revenue, institutional sales dominated the global weight loss and obesity management market in 2017.

Weight Loss And Obesity Management Market Reports - Table of Contents
1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Key Success Factors

3.1. Regulatory Scenario

3.2. Pipeline Assessment

3.3. Potential of Anti-Obesity Drugs In The Market

3.4. Key Market Entry Strategies

3.5. White Space Analysis

4. Global Weight Loss and Obesity Management Market - Pricing Analysis

4.1. Regional Pricing Analysis By Product Type

4.2. Pricing Break-up

4.2.1. Manufacturer Level Pricing

4.2.2. Distributor Level Pricing

4.3. Global Average Pricing Analysis Benchmark

5. Global Weight Loss and Obesity Management Market Demand (in Value or Size in US$ Mn) Analysis 2013-2017 and Forecast, 2018-2028

5.1. Historical Market Value (US$ Mn) Analysis, 2013-2017

5.2. Current and Future Market Value (US$ Mn) Projections, 2018-2028

5.2.1. Y-o-Y Growth Trend Analysis

5.2.2. Absolute $ Opportunity Analysis

6. Market Background

6.1. Macro-Economic Factors

6.1.1. Increasing Investments Towards Obesity Treatment

6.1.2. Global Increase In Healthcare Spending

6.1.3. Shift Towards A Value-Based Healthcare Model

6.2. Forecast Factors - Relevance & Impact

6.2.1. New/Approved Product Launches

6.2.2. Treatment Rate

6.2.3. Prevalence of Obesity

6.2.4. Technological Advancements

6.2.5. Acceptance of Drugs by Prescribers

6.2.6. Reimbursement Policies

6.2.7. Product Penetration Rate Across End Users

6.2.8. Adoption Rate among Patients

6.2.9. Product Penetration across Regions

6.2.10. Penetration of Product in Different Distribution Channel

6.3. Value Chain

6.4. Market Dynamics

6.4.1. Drivers

6.4.2. Restraints

6.4.3. Opportunity Analysis

7. Global Weight Loss and Obesity Management Market Analysis 2013-2017 and Forecast 2018-2028, by Product Type

7.1. Introduction / Key Findings

7.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2013 - 2017

7.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Product Type, 2018 - 2028

7.3.1. Devices

7.3.1.1. Liposuction Device

7.3.1.1.1. Laser Assisted Liposuction Devices

7.3.1.1.2. Radio Frequency Assisted Liposuction Devices

7.3.1.1.3. Ultrasound Assisted Liposuction Devices

7.3.1.2. Bariatric Stapling Devices

7.3.1.3. Gastric Band

7.3.1.4. Gastric Balloon Systems

7.3.1.5. Gastric Emptying Systems

7.3.1.6. Gastric Electrical Stimulation Systems

7.3.2. Drugs

7.3.2.1. GLP-1 receptor agonists

7.3.2.2. Lipase Inhibitors

7.3.2.3. Serotonin Receptor Agonist

7.3.2.4. Combination Drug

7.3.2.5. Others

7.4. Market Attractiveness Analysis By Product Type

Request to Browse Report Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-411

About Us

Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India.

FMI’s research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure our clients prepare for the evolving needs of their consumers.

Contact Us

U.S. Office

616 Corporate Way, Suite 2-9018,

Valley Cottage, NY 10989,

United States

T: +1-347-918-3531

F: +1-845-579-5705

Email: sales@futuremarketinsights.com

Blog: http://keepfacts.com/

Web: https://www.futuremarketinsights.com/

This release was published on openPR.